Along with several other NSAIDs, chronic ibuprofen use has been found correlated with risk of progression to hypertension in women, though less than for paracetamol (acetaminophen), and myocardial infarction (heart attack), particularly among those chronically using higher doses. On 9 July 2015, the US FDA toughened warnings of increased heart attack and stroke risk associated with ibuprofen and related NSAIDs; the NSAID aspirin is not included in this warning. The European Medicines Agency (EMA) issued similar warnings in 2015.